HHRI News & Press Releases
September 22, 2026 -- A transition is underway in the management of the nation's transplant data infrastructure. Publicis Sapient, a global digital business transformation company, is in the process of taking over fundamental elements of the Scientific Registry of Transplant Recipients (SRTR) contract, from the Hennepin Healthcare Research Institute (HHRI). The transition is currently in progress. The IT infrastructure transition is expected to be fully completed by December 1, 2026, with other contract element timelines yet to be determined.
SRTR is a vital national resource that supports the transplant community through comprehensive data analysis, with a core mission of improving patient outcomes and experience. It operates under a contract from the Division of Transplantation (DoT), Health Systems Bureau (HSB), Health Resources and Services Administration (HRSA), U.S. Department of Health and Human Services (HHS). The registry provides program-specific reports on transplant programs and organ procurement organizations, offering wide-ranging information to clinicians, researchers, and patients.
HHRI has been a cornerstone of medical research since 1952, supporting and overseeing research conducted at HCMC, the flagship acute care and teaching hospital of the Hennepin Healthcare System in downtown Minneapolis. As one of the largest medical research nonprofits in Minnesota, HHRI often ranks in the top ten percent nationally of institutions receiving research grants from the National Institutes of Health (NIH). The organization, through its Chronic Disease Research Group (CDRG), has operated SRTR for over 15 years with a steadfast commitment to its mission of transforming health and health care for all through ethical research and meaningful community partnerships.
The transition from HHRI to Publicis Sapient is being conducted collaboratively to ensure a seamless transfer of responsibilities and the continued integrity of SRTR's operations. Both organizations are dedicated to ensuring that the registry continues to provide reliable, data-driven insights that are essential for the transplant community and the patients they serve.
Further updates will be provided as the transition progresses.
More HHRI Research Highlights
Thank you to Dr. Jason Baker for his exceptional dedication and service as HHRI Vice President
Jason Baker, MD, MS, recently stepped down as Vice President of Hennepin Healthcare Research Institute (HHRI). Dr. Baker began his tenure as VP in January 2015 when the institute was the Minneapolis Medical Research Foundation and served in the role until December 2021. During this time, Dr. Baker was instrumental…
Read More
CDC study including Hennepin County data finds that people experiencing homelessness had significantly lower vaccination coverage compared to all residents living in the same area
In consultation with public health and housing assistance partners, CDC identified six urban, public health jurisdictions, including Hennepin County, with data on COVID-19 vaccination coverage among people experiencing homelessness. The vaccination data was reported between December 13, 2020 and August 31, 2021. The vaccination coverage and population size for the…
Read More
Increasing Trust is Key to Addressing the COVID-19 Pandemic and Other Threats to Health
As the COVID-19 pandemic continues to threaten the health of communities worldwide, researchers say that patients’ trust in the medical profession has never been more important as the health care community seeks to administer COVID vaccines en masse. Patients’ trust in the medical profession – and clinicians’ trust in their…
Read More
Dr. Winkelman talks about EHR Consortium and COVID-19 on Healthy Matters on WCCO radio
Hennepin Healthcare physician and HHRI researcher Dr. Tyler Winkelman was Dr. David Hilden’s guest Healthy Matters on WCCO 830-AM radio on Sunday, September 26, talking about the Electronic Health Records (EHR) Consortium, COVID-19 vaccinations and stats, health equity, and how Minnesota collaborates. Dr. Winkelman leads the Minnesota consortium. Their mission is to improve health…
Read More
Study identifies racial/ethnic and language inequities in ways patients obtain COVID-19 virus testing
The COVID-19 pandemic caused an unprecedented disruption to health care delivery, with resources shifted toward telehealth services and mass viral testing. While early studies in the pandemic highlighted differences in health care utilization among patients with commercial insurance, data from publicly insured or uninsured “safety-net” patient populations continue to emerge.…
Read More
Walz, Flanagan Announce Groundbreaking Partnership Between State of Minnesota, Health Care Systems on Race and Ethnicity Data Collection
— State announces additional, targeted strategies to promote equity in vaccination — The Walz-Flanagan Administration announced publication of vaccination data by race and ethnicity made possible through the groundbreaking partnership between the State of Minnesota and the Minnesota Electronic Health Record (EHR) Consortium. This unique and innovative collaboration between public…
Read More
Hennepin Healthcare takes a pulse of the pandemic
by hennepinmedical — COVID-19’s rapid arrival in Minnesota in March 2020 created myriad changes across the community – and a snapshot of that impact is now available in a report from Hennepin Healthcare. A collaboration for quality improvement between Hennepin Healthcare and Hennepin Healthcare Research Institute (HHRI) emerged to design…
Read More
Hennepin Healthcare collaborates with Mayo Clinic on convalescent plasma protocol as a therapeutic treatment for COVID-19 patients
Minneapolis, Minn. – Hennepin Healthcare Research Institute (HHRI) is collaborating with the Mayo Clinic to engage in a clinical protocol using convalescent plasma as a therapeutic treatment for COVID-19 patients. Convalescent plasma has appeared to be of benefit for the treatment of certain infectious diseases, including infections from respiratory viruses.…
Read MoreProtected: Immune Therapy and Immunology
There is no excerpt because this is a protected post.
Read More
Hennepin Healthcare partners with University of Minnesota on COVID-19 clinical trials of blood pressure drug losartan
Hennepin Healthcare Research Institute (HHRI) and University of Minnesota Medical School researchers have begun enrolling patients in newly launched clinical trials involving a blood pressure medication, losartan, as a potential treatment for those recently diagnosed with COVID-19. Both studies are multi-site trials, one for patients requiring hospitalization and the other…
Read More
Hennepin Healthcare launches two clinical trials to study the investigational antiviral drug remdesivir to treat hospitalized patients with COVID-19
Minneapolis, Minn. – April 9, 2020 – The Hennepin Healthcare Research Institute (HHRI) has launched two clinical trials to study the safety and efficacy of remdesivir to treat hospitalized patients diagnosed with moderate or severe COVID-19, the disease caused by the novel coronavirus SARS-CoV-2. Hennepin Healthcare is a clinical site…
Read More